共 649 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2019)Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review JAMA 322 764-774
[3]
Soerjomataram I(2016)Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis MOL CANCER 15 67-285
[4]
Siegel RL(2011)International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma J Thorac Oncol 6 244-550
[5]
Torre LA(2014)EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice Nature 511 543-1828
[6]
Jemal A(2013)Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing Br J Cancer 109 1821-1567
[7]
Arbour KC(2019)Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning PLOS ONE 14 e224379-2140
[8]
Riely GJ(2018)Comprehensive characterization of oncogenic drivers in asian lung adenocarcinoma NAT MED 24 1559-e459
[9]
Marshall EA(2016)Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer J Thorac Oncol 11 2129-50
[10]
Ng KW(2015)Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC Lancet Oncol 16 e447-47